Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia

Previous studies have shown that metformin or statins may decrease hepatocellular carcinoma (HCC) in diabetic patients. Accordingly, this article evaluates whether combination therapy may further reduce HCC. Newly diagnosed type 2 diabetes mellitus (DM) patients, excluding those with history of mali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Chen, Hsin-Hung, Lin, Ming-Chia, Muo, Chih-Hsin, Yeh, Su-Yin, Sung, Fung-Chang, Kao, Chia-Hung
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
4200
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616544/
https://ncbi.nlm.nih.gov/pubmed/26091447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados